Familial chronic mucocutaneous candidiasis (FCMC) is a rare, inherited disease caused by a genetically determined dysfunction of the immune system, which leads to chronic infectious pathology caused by fungi of the genus Candida. This condition is characterized by multiple relapses of mucous and skin lesions, accompanied by itching, inflammation and erosions. In most cases, the primary manifestation is observed in childhood, but clinical signs can persist into adulthood, complicating the quality of life of patients. Fungal colonization can occur on various areas of the skin, mucous membranes of the mouth, genitals and gastrointestinal tract. This disease requires a comprehensive approach to diagnosis and treatment, as well as attention from both dermatology and immunology specialists.
History of the disease and interesting historical facts
Familial chronic mucocutaneous candidiasis was first described in the medical literature in the mid-20th century. During these studies, the attention of the medical community was focused on the congenital deficiency of cellular immunity associated with the action of yeast fungi. The resistance of Candida to standard antifungal agents attracted the attention of doctors and scientists to the need to study in more detail the genetic and molecular mechanisms that underlie this disease. According to data collected in various studies, it was found that this disease is associated with mutations in several genes responsible for the functioning of the immune system. For example, in the 1970s, work was carried out on mapping genes associated with susceptibility to candidiasis, which allowed for a deeper understanding of the pathogenesis.
Epidemiology
The frequency of occurrence of familial chronic mucocutaneous candidiasis varies depending on the geographic location, race, and age of the population groups. According to the World Health Organization, cases of this disease occur in the population with a frequency of 1 in 100,000 people. The highest incidence is noted in countries with a high level of incident infectious diseases and non-specific immunodeficiencies. Some studies also report a higher prevalence in families with a history of candidiasis and other diseases associated with impaired immune response, which confirms the hereditary nature of the disease.
Genetic predisposition to this disease
Familial chronic mucocutaneous candidiasis is associated with several genetic mutations that affect immune system functions. First of all, genes responsible for the synthesis and activity of cytokines, as well as leukocyte adhesion molecules, can be mentioned in this regard. The main gene associated with this disorder is IL17, which plays a key role in the regulation of inflammatory processes and the immune response to fungal infections. They have been shown to be significant in regulating mechanisms aimed at eliminating Candida. In addition, mutations have been found in other genes, such as STAT1 and STAT3, which emphasizes the complexity of the pathogenesis of the disease.
Risk factors for the development of this disease
There are many risk factors that contribute to the development of familial chronic mucocutaneous candidiasis. These include both genetic and environmental components.
- Frequent recurrence of candidiasis in the family history.
- Constant use of antibiotics creates conditions for microbiome imbalance.
- Systemic diseases such as diabetes that can reduce the immune response.
- Disorders of the endocrine system, such as hypothyroidism or Itsenko-Cushing syndrome.
- Exposure to chemicals, allergens or stress, which leads to changes in the body's state and immune response.
Diagnosis of this disease
The main symptoms of familial chronic mucocutaneous candidiasis are itching and redness of the skin, the formation of erosions on the mucous membranes and skin, and pathological discharge. Various laboratory tests are used to diagnose the disease, including cultures on a medium with fungi, microscopy of samples, and functional tests to assess cellular immunity. Radiological examinations are usually of no use in the context of candidiasis, but can be useful for excluding other diseases. An important point is the differential diagnosis, which includes such conditions as allergic dermatitis, eczema, psoriasis, and other infections.
Treatment
Treatment of familial chronic mucocutaneous candidiasis is complex and multifaceted. It includes general health maintenance measures such as proper nutrition, daily routine, and stress reduction. Pharmacological treatment is mainly aimed at controlled antifungal drugs such as fluconazole and itraconazole, which can be used in both topical and systemic forms. In more severe cases, surgical removal of the affected areas may be required, especially if conditions for secondary bacterial infection have been created. Combination therapy options should also be considered, including the use of probiotics to help restore the normal microbiome.
List of medications used to treat this disease
- Fluconazole
- Itraconazole
- Ketoconazole
- Clotrimazole (topical)
- Nystatin (topical)
Disease monitoring
Monitoring of patients with familial chronic mucocutaneous candidiasis includes mandatory regular examinations by a dermatologist and an immunologist. The prognosis, compared to other forms of candidiasis, is difficult and can vary from complete recovery to a chronic course with frequent relapses. Complications may include secondary infections, which in some cases can be life-threatening.
Age-related features of the disease
Familial chronic mucocutaneous candidiasis may manifest itself at different ages, but most cases are recorded in childhood and adolescence. In children, the disease often occurs in a mild form, with a transition to more complex stages in adulthood. In older people, symptoms may worsen due to general immune dysfunction.
Questions and Answers
- What are the main symptoms of familial chronic mucocutaneous candidiasis?
The main symptoms include chronic itching, redness, erosion of the skin and mucous membranes, and changes in discharge. - How is the disease diagnosed?
Diagnosis involves laboratory tests such as cultures and microscopy of samples, as well as questioning the patient to understand his or her medical history. - What is the main cause of this disease?
This disease is caused by a genetically determined dysfunction of the immune system, which leads to an overgrowth of Candida fungi. - How to treat familial chronic mucocutaneous candidiasis?
Treatment includes antifungal medications such as fluconazole and itraconazole, as well as health maintenance and skin care measures. - What is the likelihood of recurrence of the disease?
Its probability can be high, especially without a comprehensive approach to treatment and monitoring of the patient's health condition.
Advice from Dr. Oleg Korzhikov
According to Dr. Oleg Korzhikov, it is important to remember that with familial chronic mucocutaneous candidiasis, it is necessary to follow several simple but effective recommendations. Maintaining good hygiene, using mild dermatological products and avoiding unexpected changes in nutrition can significantly reduce the risk of relapses. It also makes sense to pay attention to interaction with allergens and try to avoid overheating the skin, which can contribute to an exacerbation of symptoms.
